Cited by — Microbiome-targeted antibiotics provide no additional microbiologic or inflammatory benefit during cystic fibrosis pulmonary exacerbations: results from the CFMATTERS trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Microbiome-targeted antibiotics provide no additional microbiologic or inflammatory benefit during cystic fibrosis pulmonary exacerbations: results from the CFMATTERS trial.
No admitted local citation edges point to this work yet.
